Free Newsletter
AZ appeals $215M Medicaid verdict
AstraZeneca asked an Alabama judge to toss out or reduce a $215 million jury verdict in a Medicaid drug price fraud lawsuit, saying that the state didn't prove that AstraZeneca deliberately caused the Medicaid system to overpay for drugs. A ruling is expected within 10 days. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: